China

George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

George Clinical in China

China is George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

With its immense potential for patient recruitment and a rapidly growing pharmaceutical market, China, currently the third largest in the world, is an obvious choice for many when entering the Asian market.

The Chinese healthcare delivery system consists of public hospitals and community healthcare centers, with an increasing private care system. Only GCP accredited sites are eligible for running commercial Phase I, II and III studies, and this accreditation can only be achieved by public hospitals in China. The accreditation is issued by the CFDA and NHPFC based upon a site inspection. Accreditation is renewed every 3 years, with a quality review performed by the PFDA every year.

George Clinical has an extensive network of over 260 trial centers in 50 cities for Phase II-IV trials, and a wider network that includes community health centers in semi-urban and rural areas for Phase IV trials.

What are the benefits of conducting clinical trials in China?

  • China has access to a large patient pool
  • Rapidly developing medical infrastructure in urban centres and centres of excellence for many common diseases such as hypertension, diabetes and renal disease
  • Low operational costs

What are the prevalent diseases in China?

  1. Stroke
  2. Ischaemic Heart Disease
  3. Chronic obstructive pulmonary disease
  4. Cancer
  5. Road injury
  6. Hypertension
  7. Diabetes mellitus
  8. Lower respiratory infections

George Clinical China News

中澳研究人员共同探讨低钠盐饮食与脑卒中关系

2018年9月19日,‘低钠盐与脑卒中关系研究’在青岛举行了2017-2018年度会议。来自中国和澳大利亚的项目主要负责人以及开展研究的五个省项目负责人、地方疾病预防控制中心和公共卫生系统的五十余人参加会议,汇报项目进展并总结经验。

Experts from China and Australia Congregate in Qingdao to Promote SSaSS Study

On September 19 2018, the ‘Salt Substitute and Stroke Study (SSaSS) Annual Meeting 2018’ was held in Qingdao. Over 50 participants joined the meeting to review progress on the study and exchange experiences. Those who attended the meeting included Principal Inve...

临床研究设计与数据分析培训会成功举办

由心联乔治心脏健康研究中心(以下简称:心联乔治)开展的2018临床研究设计与数据分析培训会于9月17日在北京成功举办。逾40位来自全国16家医院的医生骨干及医疗行业从业人员怀着空杯的心态,完成了为期两天的培训课程

The 2018 Design and Statistical Analysis of Clinical Studies Training Program was successfully held

The 2018 Design and Statistical Analysis of Clinical Studies Training Program, organized by the Heart Health Research Center (hereafter abbreviated as HHRC), was successfully held in Beijing on September 17 2018. Over 40 doctors, trainees and medical practitioners, ...

乔治全球健康研究院的全球研究地位获得认可

乔治全球健康研究院在澳大利亚的独立研究机构排名中位于榜首,在全球范围内位列第33名。《泰晤士高等教育》基于领域权重引用影响系数(FWCI)对全球的非大学机构以及非商业性研究机构进行了评估。

Global Research Recognition for The George Institute

The George Institute for Global Health has been ranked the top independent research organisation in Australia, and come in at 33rd overall in the world.

Contact

George Clinical Address:
Level 18, Tower B, Horizon Tower
Haidian District
Beijing, 100088
P.R. China

2223, 22/F Tomson Commercial Building,
710 Dongfang Road, Pudong District
Shanghai, 200122
P.R. China

Details

Number of Personnel: 50
In-country Services:

Beijing
Project Management, Clinical Operations, Data Management, Medical and Safety Services, Clinical Compliance, Regulatory Services, Statistics, Health Economics

Shanghai
Clinical Operations

Chengdu
Clinical Operations

Harbin
Project Management, Clinical Operations

Population: 1.4 billion
Official Language: Putonghua (Mandarin). Local dialects may be used
Hospital Records Language: Simplified Chinese
Electronic Hospital Records: Currently, paper records are used.

Twitter Facebook LinkedIn